Induction Heal. Regulatory News (INHC)

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

Directorate Change

Appointment of new Chairman

Induction (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces that Christopher Samler has been appointed as Non-Executive Chairman. Christopher takes over from Chris Spencer, with immediate effect, after an externally facilitated recruitment process.

Christopher has held a number of roles as Chief Executive Officer and Chair of quoted companies (both Main Market and AIM) and private businesses in the education, healthcare, services and technology sectors. He also has significant experience supporting growth for businesses across the U.S. and Europe, as well as emerging economies in Asia, Latin America and the Middle East.

Christopher started his career in the British Army before joining The Boston Consulting Group as an analyst which led to a variety of senior general management positions at Baxter International, the US-based healthcare multinational. Subsequently, Christopher was Chief Executive Officer of a series of fast-growing venture capital backed healthcare businesses including Imutran Ltd and Weston Medical plc, the latter of which he took through three venture capital funding rounds to an IPO on the Main Market of the London Stock Exchange in 2000.

In 2004, Christopher co-founded Iceni Capital LLP, a successful private equity / venture capital firm focused on providing capital and operational support to fast growing UK companies in the services sector. More recently, he has chaired a number of high growth technology, healthcare and service companies including TQ Education & Training, AirPortr, Sphonic Solutions, Bubble and Tristel plc.

Christopher holds an MA (hons) from the University of Oxford and an MBA from the Harvard Business School.

Chris Spencer is leaving, following the completion of his three year term, to pursue non-commercial projects and spend more time with his family.

Chris Spencer, former Chair said: "Having chaired the Board since the Company's IPO, I am pleased to be departing at a time when Induction has strongly ended the financial year to 31 March 2022, announced substantial contract renewals, and successfully begun a period of transition into a growth phase."

Induction CEO, James Balmain, said: "I am thrilled to welcome Christopher to the Board of Induction and look forward to working alongside him. Christopher has a wealth of directly relevant expertise that will be invaluable as we drive the business through this next phase of growth.

"I would like to genuinely thank Chris Spencer for the great contribution he's made to Induction and the support he's given me personally as a first time public markets CEO. Chris leaves Induction in a strong position, with solid foundations and a very bright future. I wish him the very best for the future."

Disclosures in accordance with the AIM Rules

Mr. Christopher Hadley Samler, 64, is, or has been, a director or partner of the following companies or partnerships during the past five years:

Current directorships and partnerships:

Cwm Cloch MJC Hydro Ltd

Airportr Technologies Limited

Tribo Technologies Limited

Nant Hir Hydro Scheme Limited

Maes Elwy Hydro Limited

Previous directorships and partnerships held in the past five years:

Creeton with Counthorpe Broadband Community Interest Company (dissolved)

Symphonic Solutions Limited

Future Digital Footprint Limited

La Salle Education Limited

Laundrapp Limited

Mr. Samler owns no shares in Induction.

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

-ENDS-

ENQUIRIES

About Induction -  www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.